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Palladium(II)-catalysed total synthesis of naturally
occurring pyrano[3,2-a]carbazole and
pyrano[2,3-b]carbazole alkaloids†‡
Ronny Hesse, Anne Jäger, Arndt W. Schmidt and Hans-Joachim Knölker*
Seven naturally occurring pyranocarbazole alkaloids (pyrayafoline A–E, O-methylmurrayamine A and
O-methylmahanine) have been obtained by total synthesis using a palladium(II)-catalysed oxidative
cyclisation of a diarylamine to an orthogonally diprotected 2,7-dihydroxycarbazole as key step.
Introduction
Plants of the genera Murraya, Clausena and Glycosmis are the
main terrestrial source for the isolation of carbazole alkaloids.1
Various species of these plants have been applied in Asian folk
medicine for the treatment of numerous diseases. It is
assumed that carbazole alkaloids play a central role in the
pharmacological effect of the plant extracts because of their
wide range of biological activities.2 Therefore, a variety of clas-
sical methods and new procedures using transition metals
have been developed for the synthesis of carbazoles.1,3 We
reported the application of iron-mediated4 and palladium(II)-
catalysed approaches for the synthesis of carbazole deriva-
tives.5 Herein, we describe the application of our palladium(II)-
catalysed cyclisation of diarylamines to the synthesis of seven
pyranocarbazole natural products: the pyrayafolines A–E (1–5),
O-methylmurrayamine A (6) and O-methylmahanine (7)
(Fig. 1).
Pyrayafoline A (1) was first isolated by Furukawa and co-
workers in 1986 from the stem bark of Murraya euchrestifolia
Hayata collected in Taiwan.6 The structure was assigned based
on the spectroscopic data and confirmed by synthesis. In 1991,
the same group reported the isolation of the pyrayafolines B
(2), C (3) and D (4) from the same natural source.7 In their
studies, Furukawa et al. reported the O-methylation of natural
pyrayafoline B–D (2–4) using diazomethane, and the total syn-
thesis of O-methylpyrayafoline B and O-methylpyrayafoline C,
which is equivalent to pyrayafoline A (1). The structural assign-
ments for 2 and 3 were then confirmed by comparison of the
spectroscopic data of the different O-methyl derivatives.
Although pyrayafoline D (4) is chiral, the natural product
did not show any optical rotation ([α]D = ±0, c 0.0013, MeOH).
Pyrayafoline D (4) was also obtained by Itoigawa et al. from the
leaves of Murraya koenigii collected in Bangladesh.8 In 1991,
Furukawa and co-workers reported the isolation of pyrayafoline
E (5) from the stem bark of Murraya euchrestifolia Hayata.9 The
structural assignment for 5 was based solely on its spectro-
scopic data. As reported for pyrayafoline D (4), pyrayafoline E
Fig. 1 Naturally occurring pyrano[3,2-a]carbazole and pyrano[2,3-b]-
carbazole alkaloids.
†Part 113 of Transition Metals in Organic Synthesis; for Part 112, see ref. 5m.
‡Electronic supplementary information (ESI) available: 1H and 13C NMR spectra
for all compounds. CCDC 959119 and 959120. For ESI and crystallographic data
in CIF or other electronic format see DOI: 10.1039/c4ob00367e
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(5) did not exhibit any optical rotation ([α]D = ±0, c 0.0007,
CHCl3). In the plant material which afforded pyrayafoline E
(5), Furukawa and co-workers also identified pyrayafolines B–D
(2–4) and other carbazole alkaloids. O-Methylmurrayamine A
(6) was mentioned first in 1991 by Wu as a synthetic derivative
of murrayamine A, which had been isolated from the leaves of
Murraya euchrestifolia collected in Taiwan.10 In 2003, Nakatani
and co-workers described the isolation of O-methylmurraya-
mine A (6) from the leaves of Murraya koenigii collected in
Malaysia.11 In 2009, compound 6 was also isolated by Mukha-
padhyay et al. from Murraya koenigii collected in India.12 In
2011, we reported the first total synthesis of O-methylmurraya-
mine A (6) using an iron-mediated approach.4c O-Methylmaha-
nine (7) was mentioned first in 1972 by Kapil and co-workers
as a synthetic derivative of Mahanine.13 However, no spectro-
scopic data were disclosed. In 2003, Nakatani et al. described
the first isolation of O-methylmahanine (7) from the leaves of
Murraya koenigii collected in Malaysia.11 O-Methylmahanine
(7) was obtained as an optically active compound ([α]D = +3,
c 0.10, CHCl3). However, the absolute configuration has not
been assigned. Not much is known about the biological activi-
ties of the compounds 1–7, except for pyrayafoline D (4) which
has shown a promising cytotoxicity against a variety of cancer
cell lines.8,14
Results and discussion
We have developed a synthesis for the natural products 1–7
from a common precursor using our palladium(II)-catalysed
approach for the construction of the carbazole framework.
Retrosynthetic analysis led to the orthogonally diprotected 2,7-
dihydroxycarbazole 8 as a relay compound (Scheme 1). The
pyran ring was thought to be annulated at a later stage of the
synthesis. Carbazole 8 should be available by a palladium(II)-
catalysed oxidative cyclisation of a corresponding diarylamine
which can be obtained by the Buchwald–Hartwig amination15
of meta-bromoanisole (9) and the arylamine 10.
The arylamine 1016 was obtained from the nitrophenol 11
by formation of the triisopropylsilyl ether followed by
reduction of the nitro group (Scheme 2). The Buchwald–
Hartwig amination of m-bromoanisole (9) with the arylamine
10 using catalytic amounts of palladium(II) acetate and
SPhos (2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl)15b as
ligand led quantitatively to the diarylamine 12. Alternatively,
compound 12 is available by Buchwald–Hartwig coupling of
the silyl-protected bromocresol 14 and m-anisidine (96%
yield). The best results for the oxidative cyclisation of the diaryl-
amine 12 were achieved by heating in a microwave reactor in
the presence of catalytic amounts of freshly recrystallised palla-
dium(II) acetate and 2.5 equivalents of copper(II) acetate as
reoxidant in pivalic acid. These reaction conditions afforded
the orthogonally diprotected 2,7-dihydroxycarbazole 8 in
82% yield.
For the synthesis of the pyrayafolines A–C (1–3), the methyl
ether at C-7 of carbazole 8 was cleaved using boron tribromide
Scheme 2 Synthesis of the orthogonally diprotected 2,7-dihydroxycar-
bazole 8. Reagents and conditions: (a) 1. 1.2 equiv. TIPSCl, 1.8 equiv.
ImH, DMF, rt; 2. 4.7 equiv. iron powder, AcOH, 60 °C, 100% (two steps);
(b) 1.3 equiv. 10, 1.0 equiv. m-bromoanisole (9), 5 mol% Pd(OAc)2,
10 mol% SPhos, 1.4 equiv. Cs2CO3, PhMe, 100 °C, 100%; (c) 1.6 equiv.
TIPSCl, 2.0 equiv. ImH, DMF, rt, 97%; (d) 1.3 equiv. m-anisidine, 1.0 equiv.
14, 5 mol% Pd(OAc)2, 10 mol% SPhos, 1.4 equiv. Cs2CO3, PhMe, 100 °C,
96%; (e) 0.2 equiv. Pd(OAc)2, 2.5 equiv. Cu(OAc)2, PivOH, microwave
(300 W), 110 °C, 82%.
Scheme 1 Retrosynthetic analysis of the pyranocarbazoles 1–7.
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(Scheme 3). Annulation of the pyran ring was achieved by for-
mation of the dimethylpropargyl ether using Godfrey’s
method17 and subsequent thermally induced rearrangement
of the resulting aryl propargyl ether.18 Treatment of the
7-hydroxycarbazole 15 with methyl dimethylpropargyl carbo-
nate (16) in the presence of 1,8-diazabicyclo[5.4.0]undec-1(8)-
ene (DBU) and catalytic amounts of copper(II) chloride fol-
lowed by heating of the intermediate propargyl ether in
toluene at reflux afforded a mixture of the protected pyrano-
carbazoles 17 and 18 in a ratio of 5.3 : 1 in favour of the pyrano-
[3,2-a]carbazole 17. Both isomers were separated from each
other by column chromatography and fully characterised by
their spectroscopic data (see the Experimental section). The
pyran ring formation results from a thermally induced
sequence of an aryl-Claisen rearrangement followed by a 1,5-
hydrogen shift and electrocyclic ring closure (Scheme 4).19
Pyran annulation following Casiraghi’s method (reaction of 15
with prenal in the presence of titanium tetraisopropoxide in
toluene at room temperature),20 which proved to be superior
in our previous study,5k provided compound 17 only in up to
34% yield. Cleavage of the silyl ether of 17 afforded pyraya-
foline C (3) in eight steps and 39% overall yield based on com-
pound 11. Chemoselective O-methylation of pyrayafoline C (3)
provided pyrayafoline A (1) in nine steps and 37% overall yield
based on 11. The spectroscopic data of synthetic 1 and 3 are in
agreement with those reported for the natural products.6,7 The
structure of pyrayafoline A (1) has been additionally confirmed
by single-crystal X-ray analysis (Fig. 2). Pyrayafoline B (2) was
obtained from the minor isomer 18 by cleavage of the silyl
ether in eight steps and 6% overall yield based on 11. The
spectroscopic data of our synthetic 2 are matching those
reported by Furukawa et al. for the natural product.7
The prenylated pyrayafolines D (4) and E (5) were syn-
thesised from the diprotected carbazole 8 by reaction with a
C10-building block (Scheme 5). Cleavage of the methyl ether of
8 and reaction of crude 7-hydroxycarbazole 15 with the carbo-
nate 1921 in the presence of DBU and catalytic amounts of
copper(II) chloride followed by thermal rearrangement
afforded the pyrano[3,2-a]carbazole 20 and the pyrano[2,3-b]-
carbazole 21 in a ratio of 9.6 : 1. Both isomers were separated
from each other by flash chromatography and fully character-
ised. Also in this case, application of Casiraghi’s method for
annulation of the pyran ring (reaction of 15 with citral in the
presence of titanium tetraisopropoxide in toluene at room
temperature)20 was inferior (25% yield of carbazole 20). Clea-
vage of the silyl ether of the pyrano[3,2-a]carbazole 20 provided
pyrayafoline D (4) in eight steps and 40% overall yield based
on compound 11. Analogously, silyl ether cleavage of the
pyrano[2,3-b]carbazole 21 afforded pyrayafoline E (5) in eight
steps and 3% overall yield based on 11. The spectroscopic data
of synthetic 4 and 5 are in full agreement with those reported
for the natural products.7,9
For the synthesis of the carbazole alkaloids 6 and 7 with a
pyran annulated at ring A, the silyl ether of the orthogonally
diprotected 2,7-dihydroxycarbazole 8 was cleaved first to afford
Scheme 3 Synthesis of pyrayafoline A–C (1–3). Reagents and con-
ditions: (a) 2.0 equiv. BBr3, CH2Cl2, −78 °C to rt; (b) 1. 2.0 equiv. 16, 2.0
equiv. DBU, 0.9 mol% CuCl2·2H2O, MeCN, rt; 2. PhMe, reflux, 48% 17
and 9% 18 (three steps); (c) 1.5 equiv. TBAF, DMF, −10 °C, 100%; (d) 1.3
equiv. NaH, 1.5 equiv. Me2SO4, THF, 0 °C to rt, 93%; (e) 1.5 equiv. TBAF,
DMF, −10 °C, 78%.
Fig. 2 Molecular structure of pyrayafoline A (1) in the crystal. ORTEP
plot showing thermal ellipsoids at the 50% probability level.
Scheme 4 Mechanism for annulation of the pyran ring.19
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the 2-hydroxycarbazole 22 (Scheme 6). Pyran ring annulation
by reaction of 22 with prenal (23) in the presence of titanium
tetraisopropoxide in toluene (Casiraghi’s method)20 provided
O-methylmurrayamine A (6). The present route leads to
O-methylmurrayamine A (6) in a total number of six steps and
72% overall yield which is superior to our previous synthesis
reported for this natural product.4c The structure of 6 has been
unambiguously confirmed by an X-ray crystal structure deter-
mination (Fig. 3). Reaction of the 2-hydroxycarbazole 22 with
citral (24) and titanium tetraisopropoxide afforded O-methyl-
mahanine (7) in six steps and 62% overall yield based on 11.
The spectroscopic data of our synthetic carbazole alkaloids 6
and 7 are in full agreement with those reported in the
literature.10
Conclusions
Using our palladium(II)-catalysed oxidative cyclisation of diaryl-
amines as key step, we have achieved the total syntheses of
the seven pyranocarbazole alkaloids 1–7. The orthogonally
diprotected 2,7-dihydroxycarbazole 8 served as the crucial
intermediate for these natural products. Following our syn-
thetic route, compound 8 is accessible in four steps and 82%
overall yield. Chemoselective deprotection of one of the oxygen
substituents followed by pyran ring annulation provided
pyrayafoline A (1) (9 steps, 37% overall yield), B (2) (8 steps, 6%
overall yield), C (3) (8 steps, 39% overall yield), D (4) (8 steps,
40% overall yield) and E (5) (8 steps, 3% overall yield), as well
as O-methylmurrayamine A (6) (6 steps, 72% overall yield) and
O-methylmahanine (7) (6 steps, 62% overall yield). For the pyr-
ayafolines B–E (2–5), we have described the first total
synthesis.
Experimental
General methods
All reactions were carried out in oven-dried glassware using
dry solvents under an argon atmosphere unless stated other-
wise. Acetonitrile, dichloromethane, tetrahydrofuran and
toluene were dried using a solvent purification system
(MBraun-SPS). Palladium(II) acetate was recrystallised from
glacial acetic acid. All other chemicals were used as received
from commercial sources. Flash chromatography was
performed on a Büchi Sepacore system equipped with an
UV monitor using silica gel from Acros Organics
(0.035–0.070 mm). Thin layer chromatography was performed
with TLC plates from Merck (60 F254) using UV-light for visual-
isation. Melting points were measured on a Gallenkamp MPD
Scheme 6 Synthesis of O-methylmurrayamine A (6) and O-methylma-
hanine (7). Reagents and conditions: (a) 1.5 equiv. TBAF, DMF, −10 °C to
rt, 100%; (b) 2.0 equiv. prenal (23), 4.0 equiv. Ti(OiPr)4, PhMe, −78 °C
to rt, 88%; (c) 2.0 equiv. citral (24), 4.0 equiv. Ti(OiPr)4, PhMe, −78 °C
to rt, 75%.
Scheme 5 Synthesis of pyrayafoline D (4) and E (5). Reagents and con-
ditions: (a) 2.0 equiv. BBr3, CH2Cl2, −78 °C to rt; (b) 1. 2.0 equiv. 19, 2.0
equiv. DBU, 0.5 mol% CuCl2·2H2O, MeCN, rt; 2. PhMe, reflux, 49% 20
and 4% 21 (three steps); (c) 1.5 equiv. TBAF, DMF, −5 °C, 100%; (d) 1.5
equiv. TBAF, DMF, −12 °C, 83%.
Fig. 3 Molecular structure of O-methylmurrayamine A (6) in the crystal.
ORTEP plot showing thermal ellipsoids at the 50% probability level.
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350 melting point apparatus. Ultraviolet spectra were recorded
on a Perkin Elmer 25 UV/VIS spectrometer. Infrared spectra
were recorded on a Thermo Nicolet Avatar 360 FT-IR spectro-
meter using the ATR method (Attenuated Total Reflectance).
NMR spectra were recorded on Bruker DRX 500 and Avance III
600 spectrometers. Chemical shifts δ are reported in parts per
million with the non-deuterated solvent as an internal stan-
dard.22 The following abbreviations have been used: s: singlet,
d: doublet, t: triplet, m: multiplet and br: broad. Mass spectra
were recorded on a Finnigan MAT-95 spectrometer (electron
impact, 70 eV) or by GC/MS-coupling using an Agilent Techno-
logies 6890 N GC System equipped with a 5973 Mass Selective
Detector (electron impact, 70 eV). ESI-MS spectra were
recorded on an Esquire LC with an ion trap detector from
Bruker. Positive and negative ions were detected. Elemental
analyses were measured on an EuroVector EuroEA3000
elemental analyser. X-ray analyses: Bruker–Nonius Kappa
CCD equipped with a 700 series Cryostream low temperature
device from Oxford Cryosystems. Software: SHELXS-97
(G. M. Sheldrick, 1997), SADABS version 2.10 (G. M. Sheldrick,
Bruker AXS Inc., 2002), SHELXL-97 (G. M. Sheldrick, 1997),
ORTEP-3 for Windows.23
4-Methyl-3-(triisopropylsilyloxy)aniline (10). Chlorotriisopro-
pylsilane (4.92 g, 25.5 mmol) was added at room temperature
to a solution of 2-methyl-5-nitrophenol (11) (3.27 g,
21.4 mmol) and imidazole (2.67 g, 39.2 mmol) in DMF
(20 mL) and the reaction mixture was stirred for 17.5 h at
room temperature. The mixture was diluted with diethyl ether,
washed with water, 2 M hydrochloric acid, and brine. The
aqueous layers were extracted with ethyl acetate, the organic
layers were combined and the solvent was evaporated. The
residue was dried under high vacuum to provide 4-nitro-2-(tri-
isopropylsilyloxy)toluene in sufficient purity. This material was
dissolved in glacial acetic acid (100 mL) and iron powder
(5.57 g, 99.7 mmol) was added. The mixture was vigorously
stirred at 60 °C in air for 3 h. This was most conveniently done
in a large flask on the rotary evaporator. The solvent was
removed under reduced pressure. Diethyl ether and a saturated
solution of sodium hydrogencarbonate were added and the
suspension was transferred to a separation funnel. The
organic layer was separated and washed with water, a saturated
solution of sodium hydrogencarbonate and brine. The com-
bined aqueous layers were extracted with ethyl acetate and the
combined organic layers were dried over sodium sulfate. The
solvent was evaporated and the residue was purified by
column chromatography on silica gel (petroleum ether–diethyl
ether, gradient elution, 5 : 1 to 1 : 1) to provide 4-methyl-3-(tri-
isopropylsilyloxy)aniline (10) as a light red oil, yield: 5.98 g
(21.4 mmol, 100%). UV (MeOH): λ (nm) = 290 nm; IR (ATR):
ν = 3350, 2942, 2892, 2865, 1611, 1585, 1557, 1541, 1509, 1460,
1435, 1392, 1311, 1277, 1258, 1204, 1179, 1126, 1070, 1001,
969, 919, 881, 843, 798, 750, 677, 618 cm−1; 1H NMR
(500 MHz, CDCl3): δ = 1.12 (d, J = 7.4 Hz, 18 H), 1.29 (m, 3 H),
2.13 (s, 3 H), 3.46 (br s, 2 H), 6.18 (d, J = 2.3 Hz, 1 H), 6.22 (dd,
J = 7.9, 2.3 Hz, 1 H), 6.88 (d, J = 7.9 Hz, 1 H); 13C NMR and
DEPT (125 MHz, CDCl3): δ = 13.02 (3 CH), 16.18 (CH3), 18.04
(6 CH3), 105.90 (CH), 107.84 (CH), 118.72 (C), 131.11 (CH),
145.06 (C), 154.85 (C); MS (EI): m/z (%) = 279 (63) [M+], 236
(100), 208 (39), 180 (26), 106 (25).
N-(3-Methoxyphenyl)-4-methyl-3-(triisopropylsilyloxy)aniline
(12). Method A: A solution of m-bromoanisole (9) (802 mg,
4.29 mmol) in toluene (5 mL) was added at 100 °C dropwise
over a period of 10 h (using a syringe pump) to a solution of
4-methyl-3-(triisopropylsilyloxy)aniline (10) (1.56 g, 5.57 mmol),
palladium acetate (48.6 mg, 216 µmol), SPhos (178 mg,
432 µmol) and caesium carbonate (1.96 g, 6.03 mmol) in toluene
(15 mL). The mixture was stirred at 100 °C for 21 h. After
cooling to room temperature the solvent was evaporated and
the residue was purified by column chromatography on silica
gel (pentane–dichloromethane–ethyl acetate, gradient elution,
140 : 5 : 1 to 80 : 5 : 1) to provide N-(3-methoxyphenyl)-4-methyl-
3-(triisopropylsilyloxy)aniline (12) as a light yellow oil, yield:
1.65 g (4.29 mmol, 100%). UV (MeOH): λ = 215 (sh), 281,
306 nm; IR (ATR): ν = 3390, 2943, 2892, 2865, 1595, 1558, 1500,
1459, 1436, 1389, 1279, 1206, 1178, 1153, 1125, 1047, 1005,
947, 923, 881, 838, 804, 763, 717, 681 cm−1; 1H NMR
(500 MHz, acetone-d6): δ = 1.12 (d, J = 7.5 Hz, 18 H), 1.32 (m, 3
H), 2.17 (s, 3 H), 3.74 (s, 3 H), 6.40 (ddd, J = 8.1, 2.1, 0.5 Hz,
1 H), 6.62 (t, J = 2.2 Hz, 1 H), 6.64–6.66 (m, 2 H), 6.71 (d, J =
2.1 Hz, 1 H), 7.01 (d, J = 8.1 Hz, 1 H), 7.10 (t, J = 8.1 Hz, 1 H),
7.31 (br s, 1 H); 13C NMR and DEPT (125 MHz, acetone-d6): δ =
13.73 (3 CH), 16.54 (CH3), 18.42 (6 CH3), 55.29 (CH3), 103.32
(CH), 105.80 (CH), 108.98 (CH), 110.07 (CH), 111.80 (CH),
120.94 (C), 130.62 (CH), 131.94 (CH), 143.27 (C), 146.42 (C),
155.48 (C), 161.75 (C); MS (EI): m/z (%) = 385 (96) [M+], 342
(100), 314 (24), 300 (14), 143 (22); Elemental analysis calcd for
C23H35NO2Si: C 71.64, H 9.15, N 3.63; found: C 71.85, H 9.39,
N 3.73%.
4-Bromo-2-(triisopropylsilyloxy)toluene (14). Chlorotriiso-
propylsilane (4.36 g, 25.6 mmol) was added to a solution of
5-bromo-2-methylphenol (13) (3.02 g, 16.1 mmol) and imidazole
(2.20 g, 32.3 mmol) in DMF (20 mL) and the reaction mixture
was stirred at room temperature for 21.5 h. The mixture was
diluted with diethyl ether, washed with water, 2 M hydro-
chloric acid, and brine. The aqueous layers were extracted with
diethyl ether and the solvent was evaporated. Purification of
the residue by column chromatography on silica gel (pentane)
provided 4-bromo-2-(triisopropylsilyloxy)toluene (14) as a col-
ourless oil, yield: 5.35 g (15.6 mmol, 97%). UV (MeOH): λ = 224
(sh), 277, 285 nm; IR (ATR): ν = 2944, 2891, 2867, 1589, 1575,
1484, 1465, 1420, 1396, 1266, 1249, 1191, 1125, 1072, 1013,
989, 932, 881, 850, 797, 723, 704, 680, 645, 630 cm−1; 1H NMR
(500 MHz, CDCl3): δ = 1.11 (d, J = 7.4 Hz, 18 H), 1.30 (m, 3 H),
2.18 (s, 3 H), 6.90 (m, 1 H), 6.95–6.99 (m, 2 H); 13C NMR and
DEPT (125 MHz, CDCl3): δ = 12.92 (3 CH), 16.63 (CH3), 17.97
(6 CH3), 118.84 (C), 121.04 (CH), 123.59 (CH), 127.68 (C),
131.81 (CH), 155.06 (C); MS (EI): m/z (%) = 344 (27), 342 (27)
[M+], 301 (100), 299 (98), 273 (46), 271 (46), 245 (68), 243 (69),
231 (31), 229 (35), 149 (46); Elemental analysis calcd for
C16H27BrOSi: C 55.97, H 7.93; found: C 56.04, H 8.19%.
N-(3-Methoxyphenyl)-4-methyl-3-(triisopropylsilyloxy)aniline
(12). Method B: A solution of 4-bromo-2-(triisopropylsilyloxy)-
Paper Organic & Biomolecular Chemistry
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toluene (14) (1.00 g, 2.92 mmol) in toluene (10 mL) was added
at 100 °C dropwise over a period of 7.5 h (using a syringe
pump) to a solution of m-anisidine (466 mg, 3.79 mmol), palla-
dium acetate (33.4 mg, 149 µmol), SPhos (121 mg, 294 µmol)
and caesium carbonate (1.33 g, 4.08 mmol) in toluene
(20 mL). The mixture was stirred at 100 °C for 20.5 h. After
cooling to room temperature, the mixture was filtered over
Celite® 557 (ethyl acetate), the solvent was evaporated and the
residue was purified by flash chromatography on silica gel
(pentane–dichloromethane–ethyl acetate, gradient elution,
140 : 5 : 1 to 80 : 5 : 1) to provide diarylamine 12 as a light yellow
oil, yield: 1.08 g (2.79 mmol, 96%). Spectral data: see above.
7-Methoxy-3-methyl-2-(triisopropylsilyloxy)-9H-carbazole (8).
Three batches of cyclisation mixture were prepared as follows:
A 10 mL microwave tube was charged with diarylamine 12, pal-
ladium acetate, copper(II) acetate and pivalic acid in air and
the tube was irradiated in the microwave reactor at 110 °C and
300 W for 3 h. Batch 1: 511 mg (1.33 mmol) 12, 64.8 mg (289
µmol) Pd(OAc)2, 602 mg (3.31 mmol) Cu(OAc)2, 1.13 g
(11.1 mmol) PivOH; Batch 2: 519 mg (1.35 mmol) 12, 63.9 mg
(285 µmol) Pd(OAc)2, 614 mg (3.38 mmol) Cu(OAc)2, 1.09 g
(10.6 mmol) PivOH; Batch 3: 457 mg (1.19 mmol) 12, 56.3 mg
(251 µmol) Pd(OAc)2, 538 mg (2.96 mmol) Cu(OAc)2, 1.10 g
(10.8 mmol) PivOH. After completion of the reaction the three
batches were combined, diluted with diethyl ether and the sus-
pension was washed with water, a saturated aqueous solution
of potassium carbonate and brine. The aqueous layers were
extracted with diethyl ether, the combined organic layers were
dried over sodium sulfate and the solvent was evaporated.
Purification of the residue by column chromatography on
silica gel (pentane–dichloromethane–ethyl acetate, gradient
elution, 100 : 5 : 1 to 30 : 5 : 1) provided the carbazole 8 as light
yellow crystals, yield: 1.21 g (3.16 mmol, 82%). m.p. 175–176 °C.
UV (MeOH): λ = 211, 236, 259 (sh), 264, 311, 323 nm; Fluorescence
(MeOH): λex = 264 nm, λem = 354 nm; IR (ATR): ν = 3387, 3058,
3008, 2943, 2889, 2864, 1612, 1500, 1470, 1397, 1344, 1325, 1301,
1269, 1226, 1198, 1160, 1144, 1105, 1072, 1033, 1008, 944, 860,
826, 806, 767, 709, 675, 645, 608 cm−1; 1H NMR (500 MHz,
acetone-d6): δ = 1.16 (d, J = 7.5 Hz, 18 H), 1.38 (m, 3 H), 2.37 (s,
3 H), 3.83 (s, 3 H), 6.74 (dd, J = 8.5, 2.3 Hz, 1 H), 6.96 (d, J =
2.3 Hz, 1 H), 6.97 (s, 1 H), 7.72 (s, 1 H), 7.81 (d, J = 8.5 Hz, 1 H),
9.88 (br s, 1 H); 13C NMR and DEPT (125 MHz, acetone-d6): δ =
13.81 (3 CH), 17.80 (CH3), 18.48 (6 CH3), 55.69 (CH3), 95.52 (CH),
100.78 (CH), 108.16 (CH), 117.99 (C), 118.19 (C), 120.56 (CH),
120.74 (C), 121.39 (CH), 140.57 (C), 142.28 (C), 153.05 (C), 159.07
(C); MS (EI): m/z (%) = 383 (100) [M+], 340 (49), 325 (12), 312 (12),
298 (13), 238 (21), 226 (21), 167 (11); Elemental analysis calcd for
C23H33NO2Si: C 72.01, H 8.67, N 3.65; found: C 71.94, H 8.70, N
3.78%.
7-Hydroxy-3-methyl-2-(triisopropylsilyloxy)-9H-carbazole (15).
A 1 M solution of boron tribromide in dichloromethane
(1.05 mL, 1.05 mmol) was added at −78 °C over a period of
3 min to a solution of 7-methoxy-3-methyl-2-(triisopropylsilyl-
oxy)-9H-carbazole (8) (202 mg, 527 µmol) in dichloromethane
(20 mL) and the solution was allowed to gradually warm to
room temperature. The reaction mixture was stirred for 14 h
45 min and methanol (1 mL) was added. The solution was
diluted with dichloromethane and washed with water and
brine. The aqueous layers were extracted with diethyl ether,
the combined organic layers were dried over sodium sulfate
and the solvent was evaporated. Purification of the residue by
column chromatography on silica gel (petroleum ether–ethyl
acetate, gradient elution, 1 : 0 to 7 : 3) afforded 7-hydroxy-3-
methyl-2-(triisopropylsilyloxy)-9H-carbazole (15) as a yellow oil,
yield: 185 mg (501 µmol, 95%). 1H NMR (500 MHz, acetone-
d6): δ = 1.16 (d, J = 7.5 Hz, 18 H), 1.38 (m, 3 H), 2.36 (s, 3 H),
6.68 (dd, J = 8.4, 2.1 Hz, 1 H), 6.86 (d, J = 2.1 Hz, 1 H), 6.93 (s,
1 H), 7.68 (s, 1 H), 7.74 (d, J = 8.4 Hz, 1 H), 8.17 (s, 1 H), 9.77
(br s, 1 H); 13C NMR and DEPT (125 MHz, acetone-d6): δ =
13.80 (3 CH), 17.78 (CH3), 18.48 (6 CH3), 97.40 (CH), 100.71
(CH), 108.81 (CH), 117.34 (C), 118.45 (C), 120.46 (C), 120.55
(CH), 121.18 (CH), 140.46 (C), 142.56 (C), 152.80 (C), 156.41
(C); MS (EI): m/z (%) = 369 (100) [M+], 326 (58), 298 (16), 284
(15), 224 (25), 196 (16), 135 (25).
O-(Triisopropylsilyl)pyrayafoline C (17) and O-(triisopropyl-
silyl)pyrayafoline B (18). A 1 M solution of boron tribromide
in dichloromethane (2.13 mL, 2.13 mmol) was added dropwise
at −78 °C over a period of 5 min to a solution of carbazole 8
(409 mg, 1.07 mmol) in dichloromethane (15 mL). The reac-
tion mixture was stirred for 18 h while gradually warming to
room temperature. Methanol (3 mL) was added, and the
mixture was diluted with diethyl ether and washed with water
and brine. The aqueous layers were extracted with diethyl
ether and the combined organic layers were dried over sodium
sulfate. The solvent was evaporated and the resulting oil was
dried under high vacuum to provide crude 7-hydroxy-3-methyl-
2-(triisopropylsilyloxy)-9H-carbazole (15), yield: 421 mg. A solu-
tion of methyl 2-methylbut-3-yn-2-yl carbonate (16) (303 mg,
2.13 mmol) in acetonitrile (10 mL) was added dropwise over a
period of 10 h to a solution of crude 15 (421 mg), copper(II)
chloride dihydrate (1.6 mg, 9.4 µmol) and DBU (319 µL,
325 mg, 2.13 mmol) in degassed acetonitrile (60 mL) and the
mixture was stirred at room temperature for 19 h. Diethyl ether
was added and the mixture was washed with water and brine.
The aqueous layers were extracted with diethyl ether, the com-
bined organic layers were dried over sodium sulfate, the
solvent was evaporated and the residue was dried under high
vacuum. The crude mixture was dissolved in toluene (30 mL)
and heated at reflux for 23 h. The reaction mixture was cooled
to room temperature and the solvent was evaporated. Purifi-
cation of the residue by column chromatography on silica gel
(pentane–dichloromethane–ethyl acetate, gradient elution,
140 : 5 : 1 to 70 : 5 : 1) provided the less polar O-TIPS-pyraya-
foline C (17) as light yellow crystals, yield: 222 mg (509 µmol,
48%), m.p. 191–193 °C. UV (MeOH): λ = 221, 239, 284 (sh),
295, 336, 352 (sh) nm; Fluorescence (MeOH): λex = 239 nm,
λem = 353 nm; IR (ATR): ν = 3357, 3041, 3015, 2941, 2883, 2862,
1629, 1592, 1576, 1471, 1419, 1401, 1362, 1316, 1297, 1273,
1221, 1162, 1116, 1069, 1034, 988, 915, 882, 851, 836, 795, 740,
720, 674, 602 cm−1; 1H NMR (500 MHz, acetone-d6): δ = 1.16
(d, J = 7.5 Hz, 18 H), 1.38 (m, 3 H), 1.43 (s, 6 H), 2.36 (s, 3 H),
5.75 (d, J = 9.8 Hz, 1 H), 6.59 (d, J = 8.3 Hz, 1 H), 6.86 (d, J =
Organic & Biomolecular Chemistry Paper
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9.8 Hz, 1 H), 6.94 (s, 1 H), 7.68 (d, J = 8.3 Hz, 1 H), 7.70 (s,
1 H), 10.08 (br s, 1 H); 13C NMR and DEPT (125 MHz, acetone-
d6): δ = 13.80 (3 CH), 17.79 (CH3), 18.47 (6 CH3), 27.78 (2 CH3),
76.30 (C), 100.85 (CH), 105.67 (C), 109.52 (CH), 118.33 (CH),
118.46 (C), 118.50 (C), 120.12 (CH), 121.01 (C), 121.42 (CH),
130.12 (CH), 137.59 (C), 140.60 (C), 151.39 (C), 153.11 (C); MS
(EI): m/z (%) = 435 (16) [M+], 420 (100), 292 (7), 161 (16);
Elemental analysis calcd for C27H37NO2Si: C 74.43, H 8.56,
N 3.21; found: C 74.09, H 8.32, N 3.14%.
O-TIPS-pyrayafoline B (18) was obtained from the more
polar fraction as a light yellow oil, yield: 40.6 mg (93.2 µmol,
9%). 1H NMR (500 MHz, CDCl3): δ = 1.16 (d, J = 7.5 Hz, 18 H),
1.35 (m, 3 H), 1.48 (s, 6 H), 2.40 (s, 3 H), 5.59 (d, J = 9.8 Hz, 1
H), 6.52 (d, J = 9.8 Hz, 1 H), 6.786 (s, 1 H), 6.789 (s, 1 H), 7.52
(s, 1 H), 7.66 (s, 1 H), 7.88 (br s, 1 H); 13C NMR and DEPT
(125 MHz, CDCl3): δ = 13.05 (3 CH), 17.54 (CH3), 18.06 (6 CH3),
27.76 (2 CH3), 76.20 (C), 97.94 (CH), 99.79 (CH), 114.83 (C),
116.80 (CH), 117.24 (C), 117.57 (C), 120.66 (CH), 121.04 (C),
123.41 (CH), 128.23 (CH), 138.96 (C), 140.45 (C), 151.23 (C),
152.54 (C); MS (EI): m/z (%) = 435 (46) [M+], 420 (100), 161 (22),
153 (13).
Pyrayafoline C (3). A 1 M solution of TBAF in THF (180 µL,
180 µmol) was added at −10 °C to a solution of O-(triisopropyl-
silyl)pyrayafoline C (17) (52.4 mg, 120 µmol) in DMF (10 mL),
the cooling bath was removed and the reaction mixture was
stirred for 10 min at room temperature. Water (10 mL) and
diethyl ether were added and the mixture was washed with
water and brine. The aqueous layers were extracted with
diethyl ether, the combined organic layers were dried over
sodium sulfate and the solvent was evaporated. Purification of
the residue by column chromatography on silica gel (pentane–
ethyl acetate, gradient elution, 5 : 1 to 3 : 1) provided pyraya-
foline C (3) as pale grey crystals, yield: 33.5 mg (120 µmol,
100%), m.p. 216 °C (ref. 7: pale yellow oil). UV (MeOH): λ =
221, 237, 285 (sh), 295, 337 nm; Fluorescence (MeOH): λex =
237 nm, λem = 354 nm; IR (ATR): ν = 3412, 3329, 3052, 2986,
2912, 2853, 1630, 1607, 1590, 1577, 1554, 1471, 1418, 1399,
1367, 1350, 1297, 1257, 1213, 1155, 1133, 1115, 1064, 1028,
995, 940, 887, 841, 823, 805, 778, 740, 718, 690, 647, 616 cm−1;
1H NMR (600 MHz, CDCl3): δ = 1.48 (s, 6 H), 2.38 (s, 3 H), 4.72
(br s, 1 H), 5.70 (d, J = 9.8 Hz, 1 H), 6.59 (d, J = 9.8 Hz, 1 H),
6.70 (d, J = 8.3 Hz, 1 H), 6.82 (s, 1 H), 7.643 (s, 1 H), 7.645 (d,
J = 8.3 Hz, 1 H), 7.75 (br s, 1 H); 13C NMR and DEPT (150 MHz,
CDCl3): δ = 16.11 (CH3), 27.52 (2 CH3), 75.85 (C), 96.74 (CH),
104.77 (C), 109.41 (CH), 116.24 (C), 116.92 (CH), 117.71 (C),
117.91 (C), 119.47 (CH), 120.96 (CH), 129.76 (CH), 136.12 (C),
139.20 (C), 150.60 (C), 152.07 (C); MS (EI): m/z (%) = 279 (16)
[M+], 264 (100), 234 (6), 132 (10); Elemental analysis calcd for
C18H17NO2: C 77.40, H 6.13, N 5.01; found: C 77.09, H 6.53,
N 4.92%.
Pyrayafoline A (1). A 1 M solution of TBAF in THF (282 µL,
282 µmol) was added at −10 °C to a solution of O-(triisopropyl-
silyl)pyrayafoline C (17) (81.8 mg, 188 µmol) in DMF (10 mL),
the cooling bath was removed and the mixture was stirred for
10 min. Water (10 mL) was added, the mixture was diluted
with diethyl ether and washed with water and brine. The
aqueous layers were extracted with diethyl ether, the combined
organic layers were dried over sodium sulfate, the solvent was
evaporated and the residue was dried under high vacuum to
provide crude pyrayafoline C (3). Without further purification,
compound 3 was dissolved in THF (10 mL), the solution was
cooled to 0 °C and sodium hydride (60% suspension in
mineral oil, 9.8 mg, 0.25 mmol) was added. The mixture was
stirred for a few minutes, dimethyl sulfate (27 µL, 36 mg,
0.28 mmol) was added, the cooling bath was removed and the
mixture was stirred for 24 h. The mixture was diluted with
diethyl ether and washed with water and brine. The aqueous
layers were extracted with diethyl ether, the combined organic
layers were dried over sodium sulfate and the solvent was evap-
orated. Purification of the residue by column chromatography
on silica gel (pentane–ethyl acetate, gradient elution, 20 : 1 to
9 : 1) provided pyrayafoline A (1) as pale grey crystals, yield:
51.5 mg (176 µmol, 93%), m.p. 229–233 °C (ref. 6: 228–231 °C).
UV (MeOH): λ = 221, 238, 284 (sh), 294, 337, 349 (sh) nm; Fluo-
rescence (MeOH): λex = 238 nm, λem = 353 nm; IR (ATR): ν =
3421, 2968, 2913, 1627, 1590, 1488, 1462, 1416, 1398, 1373,
1346, 1319, 1297, 1267, 1231, 1213, 1186, 1141, 1116, 1068,
1038, 1010, 939, 919, 881, 846, 824, 809, 779, 740, 718,
652 cm−1; 1H NMR (600 MHz, CDCl3): δ = 1.48 (s, 6 H), 2.34 (s,
3 H), 3.89 (s, 3 H), 5.70 (d, J = 9.8 Hz, 1 H), 6.61 (d, J = 9.8 Hz,
1 H), 6.70 (d, J = 8.3 Hz, 1 H), 6.85 (s, 1 H), 7.65 (s, 2 H), 7.81
(br s, 1 H); 13C NMR and DEPT (150 MHz, CDCl3): δ = 16.65
(CH3), 27.52 (2 CH3), 55.57 (CH3), 75.80 (C), 92.74 (CH), 104.74
(C), 109.38 (CH), 116.82 (C), 116.97 (CH), 117.85 (C), 119.31
(C), 119.45 (CH), 120.78 (CH), 129.70 (CH), 135.89 (C), 139.00
(C), 150.37 (C), 156.43 (C); MS (EI): m/z (%) = 293 (32) [M+], 278
(100), 263 (18), 234 (11); HRMS: m/z calcd for C19H19NO2 [M
+]:
293.1416; found: 293.1418.
Crystal data for 1: C19H19NO2, crystal size: 0.52 × 0.18 ×
0.11 mm3, M = 293.35 g mol−1, monoclinic, space group: P21,
a = 6.508(1), b = 25.907(3), c = 9.1340(1) Å, β = 99.33(1)°, V =
1519.6(3) Å3, Z = 4, ρc = 1.282 g cm
−3, µ = 0.083 mm−1, T =
198(2) K, λ = 0.71073 Å, θ range = 3.15–25.40°, reflections col-
lected: 17 349, independent: 5336 (Rint = 0.0353), 413 para-
meters. The structure was solved by direct methods and
refined by full-matrix least-squares on F2; R1 = 0.0428,
wR2 = 0.0783 [I > 2σ(I)]; maximal residual electron density:
0.161 e Å−3. CCDC 959119.
Pyrayafoline B (2). A 1 M solution of TBAF in THF (351 µL,
351 µmol) was added at −10 °C to a solution of O-(triisopropyl-
silyl)pyrayafoline B (18) (102 mg, 234 µmol) in DMF (10 mL),
the cooling bath was removed and the reaction mixture was
stirred for 10 min. Water (10 mL) was added, the mixture was
diluted with diethyl ether and washed with water and brine.
The aqueous layers were extracted with diethyl ether, the com-
bined organic layers were dried over sodium sulfate and the
solvent was evaporated. Purification of the residue by column
chromatography on silica gel (pentane–ethyl acetate, gradient
elution, 5 : 1 to 3 : 1) provided pyrayafoline B (2) as pale grey
crystals, yield: 51.0 mg (183 µmol, 78%), m.p. 187–190 °C (ref.
7: no m.p. reported). UV (MeOH): λ = 229, 253, 284, 298 (sh),
329, 353 nm; Fluorescence (MeOH): λex = 284 nm, λem =
Paper Organic & Biomolecular Chemistry
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397 nm; IR (ATR): ν = 3529, 3397, 3038, 2969, 2921, 2855, 1697,
1619, 1485, 1463, 1420, 1372, 1324, 1289, 1246, 1215, 1140,
1096, 1007, 975, 943, 884, 829, 752, 699, 681 cm−1; 1H NMR
(600 MHz, CDCl3): δ = 1.46 (s, 6 H), 2.38 (s, 3 H), 4.75 (br s,
1 H), 5.58 (d, J = 9.8 Hz, 1 H), 6.49 (d, J = 9.8 Hz, 1 H), 6.747 (s,
1 H), 6.751 (s, 1 H), 7.49 (s, 1 H), 7.63 (s, 1 H), 7.70 (br s, 1 H);
13C NMR and DEPT (150 MHz, CDCl3): δ = 16.12 (CH3), 27.87
(2 CH3), 76.27 (C), 96.63 (CH), 98.01 (CH), 115.02 (C), 116.11
(C), 116.85 (CH), 117.44 (C), 117.59 (C), 120.91 (CH), 123.30
(CH), 128.45 (CH), 139.20 (C), 140.45 (C), 151.51 (C), 152.10
(C); 1H NMR (500 MHz, acetone-d6): δ = 1.40 (s, 6 H), 2.31 (s,
3 H), 5.61 (d, J = 9.8 Hz, 1 H), 6.52 (d, J = 9.8 Hz, 1 H), 6.74 (s,
1 H), 6.89 (s, 1 H), 7.55 (s, 1 H), 7.63 (s, 1 H), 8.11 (br s, 1 H),
9.84 (br s, 1 H); 13C NMR and DEPT (125 MHz, acetone-d6): δ =
16.71 (CH3), 28.08 (2 CH3), 76.51 (C), 97.18 (CH), 98.64 (CH),
115.22 (C), 117.28 (C), 117.33 (CH), 117.45 (C), 118.54 (C),
121.41 (CH), 124.28 (CH), 128.78 (CH), 140.88 (C), 141.83 (C),
152.07 (C), 154.65 (C); MS (EI): m/z (%) = 279 (29) [M+],
264 (100), 132 (10); Elemental analysis calcd for
C18H17NO2: C 77.40, H 6.13, N 5.01; found: C 77.52, H 6.18,
N 4.80%.
O-(Triisopropylsilyl)pyrayafoline D (20) and O-(triisopropylsi-
lyl)pyrayafoline E (21). A 1 M solution of boron tribromide in
dichloromethane (1.58 mL, 1.58 mmol) was added dropwise at
−78 °C over a period of 5 min to a solution of carbazole 8
(303 mg, 790 µmol) in dichloromethane (12.5 mL). The reac-
tion mixture was stirred for 16 h while gradually warming to
room temperature. Methanol (3 mL) was added, and the
mixture was diluted with diethyl ether and washed with water
and brine. The aqueous layers were extracted with diethyl
ether and the combined organic layers were dried over sodium
sulfate. The solvent was evaporated and the resulting oil was
dried under high vacuum to provide crude 7-hydroxy-3-methyl-
2-(triisopropylsilyloxy)-9H-carbazole (15), yield: 315 mg. A solu-
tion of methyl 3,7-dimethyloct-6-en-1-yn-3-yl carbonate (19)
(332 mg, 1.58 mmol) in acetonitrile (10 mL) was added drop-
wise over a period of 10 h to a solution of crude 15 (315 mg),
copper(II) chloride dihydrate (0.7 mg, 4 µmol) and DBU (236
µL, 240 mg, 1.58 mmol) in degassed acetonitrile (40 mL) and
the mixture was stirred at room temperature for 20 h 30 min.
Diethyl ether was added and the mixture was washed with
water and brine. The aqueous layers were extracted with
diethyl ether, the combined organic layers were dried over
sodium sulfate, the solvent was evaporated and the residue
was dried under high vacuum. The crude mixture was dis-
solved in toluene (30 mL) and heated at reflux for 23 h. The
reaction mixture was cooled to room temperature and the
solvent was evaporated. Purification of the residue by column
chromatography on silica gel (pentane–dichloromethane–ethyl
acetate, gradient elution, 200 : 5 : 1 to 80 : 5 : 1) provided the
less polar O-TIPS-pyrayafoline D (20) as light yellow crystals,
yield: 193 mg (384 µmol, 49%), m.p. 99–102 °C. UV (MeOH):
λ = 222, 239, 285 (sh), 296, 324, 331, 352 (sh) nm; Fluorescence
(MeOH): λex = 296 nm, λem = 354 nm; IR (ATR): ν = 3369, 3329,
2962, 2942, 2864, 1629, 1593, 1575, 1472, 1420, 1401, 1317,
1298, 1274, 1223, 1170, 1148, 1076, 1034, 1013, 918, 880, 851,
799, 741, 722, 682, 644 cm−1; 1H NMR (500 MHz, acetone-d6):
δ = 1.16 (d, J = 7.5 Hz, 18 H), 1.38 (m, 3 H), 1.41 (s, 3 H), 1.56
(s, 3 H), 1.63 (s, 3 H), 1.72–1.75 (m, 2 H), 2.16 (m, 2 H), 2.36 (s,
3 H), 5.12 (m, 1 H), 5.75 (d, J = 9.8 Hz, 1 H), 6.60 (d, J = 8.3 Hz,
1 H), 6.90 (d, J = 9.8 Hz, 1 H), 6.94 (s, 1 H), 7.68 (d, J = 8.3 Hz,
1 H), 7.70 (s, 1 H), 10.07 (br s, 1 H); 13C NMR and DEPT
(125 MHz, acetone-d6): δ = 13.81 (3 CH), 17.64 (CH3), 17.78
(CH3), 18.47 (6 CH3), 23.42 (CH2), 25.79 (CH3), 26.18 (CH3),
41.50 (CH2), 78.67 (C), 100.86 (CH), 105.57 (C), 109.41 (CH),
118.44 (C), 118.51 (C), 118.76 (CH), 120.14 (CH), 121.01 (C),
121.42 (CH), 125.13 (CH), 129.25 (CH), 131.89 (C), 137.63 (C),
140.61 (C), 151.60 (C), 153.11 (C); ESI-MS (+25 V): m/z = 504.5
[(M + H)+]; ESI-MS (−25 V): m/z = 502.2 [(M − H)−]; Elemental
analysis calcd for C32H45NO2Si: C 76.29, H 9.00, N 2.78; found:
C 75.95, H 9.29, N 2.65%.
O-TIPS-pyrayafoline E (21) was obtained from the more
polar fraction as a light yellow oil, yield: 14.1 mg (28.0 mmol,
4%). 1H NMR (500 MHz, CDCl3): δ = 1.15 (d, J = 7.5 Hz, 18 H),
1.35 (m, 3 H), 1.43 (s, 3 H), 1.59 (s, 3 H), 1.67 (s, 3 H),
1.64–1.79 (m, 2 H), 2.16 (m, 2 H), 2.38 (s, 3 H), 5.11 (m, 1 H),
5.54 (d, J = 9.8 Hz, 1 H), 6.53 (d, J = 9.8 Hz, 1 H), 6.76 (s, 1 H),
6.78 (s, 1 H), 7.49 (s, 1 H), 7.64 (s, 1 H), 7.75 (br s, 1 H); 13C
NMR and DEPT (125 MHz, CDCl3): δ = 13.07 (3 CH), 17.55
(CH3), 17.61 (CH3), 18.09 (6 CH3), 22.74 (CH2), 25.65 (CH3),
26.26 (CH3), 41.11 (CH2), 78.48 (C), 97.71 (CH), 99.79 (CH),
114.81 (C), 116.85 (CH), 117.31 (C), 117.39 (C), 120.66 (CH),
121.10 (C), 123.87 (CH), 124.23 (CH), 127.23 (CH), 131.54 (C),
138.90 (C), 140.47 (C), 151.64 (C), 152.51 (C); ESI-MS
(+10 V): m/z = 504.5 [(M + H)+]; ESI-MS (−50 V): m/z = 502.3
[(M − H)−].
Pyrayafoline D (4). A 1 M solution of TBAF in THF (159 µL,
159 µmol) was added at −5 °C to a solution of O-(triisopropyl-
silyl)pyrayafoline D (20) (53.0 mg, 105 µmol) in DMF (10 mL),
the cooling bath was removed and the mixture was stirred for
10 min. Water (10 mL) was added, the mixture was diluted
with diethyl ether and washed with water and brine. The
aqueous layers were extracted with diethyl ether, the combined
organic layers were dried over sodium sulfate and the solvent
was evaporated. Purification of the residue by flash chromato-
graphy on silica gel (pentane–ethyl acetate, gradient elution,
6 : 1 to 4 : 1) provided pyrayafoline D (4) as pale grey crystals,
yield: 36.6 mg (105 µmol, 100%), m.p. 176–177 °C (ref. 7: no
m.p. reported). UV (MeOH): λ = 221, 238, 286 (sh), 296, 321,
330, 352 (sh) nm; Fluorescence (MeOH): λex = 238 nm, λem =
353 nm; IR (ATR): ν = 3541, 3415, 3048, 2964, 2920, 2853, 1698,
1629, 1578, 1554, 1472, 1446, 1419, 1403, 1375, 1349, 1319,
1284, 1268, 1224, 1206, 1174, 1125, 1080, 1031, 954, 907, 886,
843, 816, 780, 743, 722, 695, 655, 614 cm−1; 1H NMR
(600 MHz, CDCl3): δ = 1.44 (s, 3 H), 1.58 (s, 3 H), 1.66 (s, 3 H),
1.69–1.81 (m, 2 H), 2.09–2.20 (m, 2 H), 2.38 (s, 3 H), 4.82 (br s,
1 H), 5.10 (m, 1 H), 5.66 (d, J = 9.8 Hz, 1 H), 6.61 (d, J = 9.8 Hz,
1 H), 6.69 (d, J = 8.3 Hz, 1 H), 6.80 (s, 1 H), 7.633 (d, J = 8.3 Hz,
1 H), 7.635 (s, 1 H), 7.75 (br s, 1 H); 13C NMR and DEPT
(150 MHz, CDCl3): δ = 16.12 (CH3), 17.62 (CH3), 22.72 (CH2),
25.65 (CH3), 25.87 (CH3), 40.72 (CH2), 78.15 (C), 96.74 (CH),
104.61 (C), 109.30 (CH), 116.24 (C), 117.30 (CH), 117.57 (C),
Organic & Biomolecular Chemistry Paper
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117.89 (C), 119.43 (CH), 120.92 (CH), 124.12 (CH), 128.82 (CH),
131.69 (C), 136.13 (C), 139.19 (C), 150.79 (C), 152.04 (C); MS
(EI): m/z (%) = 347 (56) [M+], 332 (6), 278 (6), 264 (100); HRMS:
m/z calcd for C23H25NO2 [M
+]: 347.1885; found: 347.1899;
Elemental analysis calcd for C23H25NO2: C 79.51, H 7.25,
N 4.03; found: C 79.55, H 7.24, N 3.87%.
Pyrayafoline E (5). A 1 M solution of TBAF in THF (126 µL,
126 µmol) was added at −10 °C to a solution of O-(triisopropyl-
silyl)pyrayafoline E (21) (42.2 mg, 83.8 µmol) in DMF (10 mL),
the cooling bath was removed and the mixture was stirred for
10 min. Water (10 mL) was added, the mixture was diluted
with diethyl ether and washed with water and brine. The
aqueous layers were extracted with diethyl ether, the combined
organic layers were dried over sodium sulfate and the solvent
was evaporated. Purification of the residue by column chrom-
atography on silica gel (pentane–ethyl acetate, gradient
elution, 6 : 1 to 7 : 2) provided pyrayafoline E (5) as pale grey
crystals, yield: 24.1 mg (69.4 µmol, 83%), m.p. 148–149 °C (ref.
9: pale brown oil). UV (MeOH): λ = 229 (sh), 239, 253, 285, 296
(sh), 322, 354 nm; Fluorescence (MeOH): λex = 285 nm, λem =
394 nm; IR (ATR): ν = 3533, 3389, 2967, 2919, 2850, 1698, 1613,
1485, 1466, 1372, 1322, 1290, 1221, 1144, 1075, 1009, 975, 912,
884, 826, 757, 683, 600 cm−1; 1H NMR (600 MHz, CDCl3): δ =
1.42 (s, 3 H), 1.57 (s, 3 H), 1.65 (s, 3 H), 1.65–1.79 (m, 2 H),
2.12–2.17 (m, 2 H), 2.38 (s, 3 H), 4.69 (br s, 1 H), 5.10 (m, 1 H),
5.53 (d, J = 9.8 Hz, 1 H), 6.51 (d, J = 9.8 Hz, 1 H), 6.75 (s, 1 H),
6.78 (s, 1 H), 7.48 (s, 1 H), 7.62 (s, 1 H), 7.72 (br s, 1 H); 13C
NMR and DEPT (150 MHz, CDCl3): δ = 16.12 (CH3), 17.62
(CH3), 22.76 (CH2), 25.66 (CH3), 26.35 (CH3), 41.19 (CH2),
78.55 (C), 96.61 (CH), 97.78 (CH), 114.94 (C), 116.03 (C), 116.88
(CH), 117.27 (C), 117.67 (C), 120.88 (CH), 123.77 (CH), 124.23
(CH), 127.38 (CH), 131.59 (C), 139.19 (C), 140.50 (C), 151.88
(C), 152.05 (C); 1H NMR (500 MHz, acetone-d6): δ = 1.38 (s, 3
H), 1.56 (s, 3 H), 1.63 (d, J = 0.8 Hz, 3 H), 1.68–1.73 (m, 2 H),
2.13–2.18 (m, 2 H), 2.31 (s, 3 H), 5.11 (m, 1 H), 5.59 (d, J =
9.8 Hz, 1 H), 6.56 (d, J = 9.8 Hz, 1 H), 6.74 (s, 1 H), 6.89 (s,
1 H), 7.54 (s, 1 H), 7.63 (s, 1 H), 8.11 (s, 1 H), 9.84 (br s, 1 H);
13C NMR and DEPT (125 MHz, acetone-d6): δ = 16.71 (CH3),
17.63 (CH3), 23.46 (CH2), 25.79 (CH3), 26.55 (CH3), 41.85
(CH2), 78.85 (C), 97.0719 (CH), 98.39 (CH), 115.14 (C), 117.29
(C), 117.38 (CH), 117.44 (C), 118.40 (C), 121.38 (CH), 124.80
(CH), 125.21 (CH), 127.73 (CH), 131.80 (C), 140.74 (C), 141.73
(C), 152.33 (C), 154.52 (C); ESI-MS (+25 V): m/z = 348.2 [(M +
H)+]; ESI-MS (−50 V): m/z = 345.9 [(M − H)−]; MS (EI): m/z (%) =
347 (14) [M+], 332 (4), 279 (5), 269 (16), 264 (100); HRMS: m/z
calcd for C23H25NO2 [M
+]: 347.1885; found: 347.1865.
2-Hydroxy-7-methoxy-3-methyl-9H-carbazole (22). A 1 M
solution of TBAF in THF (803 µL, 803 µmol) was added at
−10 °C to a solution of 7-methoxy-3-methyl-2-(triisopropylsilyl-
oxy)-9H-carbazole (8) (205 mg, 535 µmol) in DMF (10 mL).
The cooling bath was removed and the mixture was stirred for
10 min. Water (10 mL) was added, the mixture was diluted
with diethyl ether and washed with water and brine. The
aqueous layers were dried over sodium sulfate and the solvent
was evaporated. Purification of the residue by column chrom-
atography on silica gel (pentane–ethyl acetate, gradient
elution, 4 : 1 to 2 : 1) provided 2-hydroxy-7-methoxy-3-methyl-
9H-carbazole (22) as colourless crystals, yield: 122 mg (535
µmol, 100%), m.p. 243–244 °C. UV (MeOH): λ = 209, 235, 264,
310, 322 nm; Fluorescence (MeOH): λex = 264 nm, λem =
353 nm; IR (ATR): ν = 3387, 2926, 1612, 1499, 1469, 1450, 1397,
1374, 1329, 1307, 1268, 1223, 1197, 1153, 1129, 1025, 1008,
943, 880, 851, 811, 727, 618 cm−1; 1H NMR (500 MHz, acetone-
d6): δ = 2.32 (s, 3 H), 3.82 (s, 3 H), 6.72 (dd, J = 8.5, 2.2 Hz,
1 H), 6.91 (s, 1 H), 6.92 (d, J = 2.2 Hz, 1 H), 7.66 (s, 1 H), 7.78
(d, J = 8.5 Hz, 1 H), 8.09 (s, 1 H), 9.81 (br s, 1 H); 13C NMR and
DEPT (125 MHz, acetone-d6): δ = 16.70 (CH3), 55.66 (CH3),
95.51 (CH), 97.16 (CH), 107.89 (CH), 117.16 (C), 117.33 (C),
118.28 (C), 120.23 (CH), 121.39 (CH), 140.82 (C), 142.06 (C),
154.53 (C), 158.79 (C); MS (EI): m/z (%) = 227 (100) [M+], 212
(82), 184 (33), 154 (9), 113 (10); Elemental analysis calcd for
C14H13NO2: C 73.99, H 5.77, N 6.16; found: C 73.60, H 5.75,
N 6.20%.
O-Methylmurrayamine A (6). A 1 M solution of TBAF in THF
(393 µL, 393 µmol) was added at −10 °C to a solution of
7-methoxy-3-methyl-2-(triisopropylsilyloxy)-9H-carbazole (8)
(101 mg, 262 µmol) in DMF (10 mL). The cooling bath was
removed and the mixture was stirred for 10 min. Water
(10 mL) was added, the mixture was diluted with diethyl ether
and washed with water and brine. The aqueous layers were
extracted with diethyl ether, the combined organic layers were
dried over sodium sulfate, the solvent was evaporated and the
residue was dried under high vacuum to provide crude
2-hydroxy-7-methoxy-3-methyl-9H-carbazole (22) (92.3 mg).
Prenal (23) (51 mL, 44 mg, 0.53 mmol) was added at −78 °C to
a solution of crude 22 (92.3 mg) in toluene (17 mL). At the
same temperature, titanium(IV) isopropoxide (314 µL,
1.05 mmol) was added slowly and the reaction mixture was
allowed to warm to room temperature over a period of 22 h.
The mixture was diluted with diethyl ether and washed with
water and brine. The aqueous layers were extracted with
diethyl ether, the combined organic layers were dried over
sodium sulfate and the solvent was evaporated. Purification of
the residue by column chromatography on silica gel (pentane–
ethyl acetate, gradient elution, 11 : 1 to 7 : 1) provided
O-methylmurrayamine A (6) as light yellow crystals, yield:
67.4 mg (0.230 mmol, 88%), m.p. 257–258 °C (ref. 10:
232–233 °C). UV (MeOH): λ = 220, 241, 283 (sh), 293, 342, 357
(sh) nm; Fluorescence (MeOH): λex = 241 nm, λem = 357 nm; IR
(ATR): ν = 3381, 3051, 2967, 2919, 2833, 1697, 1642, 1613,
1495, 1445, 1403, 1358, 1309, 1264, 1246, 1211, 1192, 1154,
1127, 1056, 1013, 978, 939, 892, 874, 830, 809, 781, 749, 728,
682, 664, 641 cm−1; 1H NMR (500 MHz, acetone-d6): δ = 1.45 (s,
6 H), 2.27 (s, 3 H), 3.83 (s, 3 H), 5.76 (d, J = 9.8 Hz, 1 H), 6.74
(dd, J = 8.5, 2.3 Hz, 1 H), 6.87 (d, J = 9.8 Hz, 1 H), 6.93 (d, J =
2.3 Hz, 1 H), 7.60 (s, 1 H), 7.80 (d, J = 8.5 Hz, 1 H), 10.14 (br s,
1 H); 13C NMR and DEPT (125 MHz, acetone-d6): δ = 16.20
(CH3), 27.84 (2 CH3), 55.68 (CH3), 76.33 (C), 95.68 (CH), 105.49
(C), 108.26 (CH), 117.78 (C), 118.09 (C), 118.30 (C), 118.65
(CH), 120.53 (CH), 121.00 (CH), 129.94 (CH), 136.21 (C), 142.28
(C), 149.46 (C), 159.06 (C); MS (EI): m/z (%) = 293 (35) [M+], 278
(100), 263 (12), 235 (7); Elemental analysis calcd for
Paper Organic & Biomolecular Chemistry
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C19H19NO2: C 77.79, H 6.53, N 4.77; found: C 77.29, H 6.60,
N 4.75%.
Crystal data for 6: C19H19NO2, crystal size: 0.35 × 0.21 ×
0.17 mm3, M = 293.35 g mol−1, monoclinic, space group: P21,
a = 6.763(1), b = 8.187(1), c = 13.881(1) Å, β = 91.33(1)°, V =
768.37(16) Å3, Z = 2, ρc = 1.268 g cm
−3, µ = 0.082 mm−1, T =
198(2) K, λ = 0.71073 Å, θ range = 3.01–26.00°, reflections col-
lected: 12481, independent: 2940 (Rint = 0.0421), 207 para-
meters. The structure was solved by direct methods and
refined by full-matrix least-squares on F2; R1 = 0.0386,
wR2 = 0.0854 [I > 2σ(I)]; maximal residual electron density:
0.201 e Å−3. CCDC 959120.
O-Methylmahanine (7). A 1 M solution of TBAF in THF (399
µL, 399 µmol) was added at −10 °C to a solution of 7-methoxy-
3-methyl-2-(triisopropylsilyloxy)-9H-carbazole (8) (102 mg,
266 µmol) in DMF (10 mL). The cooling bath was removed and
the mixture was stirred for 10 min. Water (10 mL) was added,
the mixture was diluted with diethyl ether and washed with
water and brine. The aqueous layers were extracted with
diethyl ether, the combined organic layers were dried over
sodium sulfate, the solvent was evaporated and the residue
was dried under high vacuum to provide crude 2-hydroxy-
7-methoxy-3-methyl-9H-carbazol (22), yield: 71.2 mg. Citral (24)
(0.091 mL, 0.53 mmol) was added at −78 °C to a solution
of crude 2-hydroxy-7-methoxy-3-methyl-9H-carbazol (22)
(71.2 mg) in toluene (15 mL). Titanium(IV) isopropoxide (318 µL,
1.06 mmol) was added slowly at the same temperature and
the reaction mixture was allowed to warm to room temperature
over a period of 23 h. The mixture was diluted with diethyl
ether and washed with water and brine. The aqueous layers
were extracted with diethyl ether, the combined organic layers
were dried over sodium sulfate and the solvent was evaporated.
Purification of the residue by column chromatography on
silica gel (pentane–ethyl acetate, gradient elution, 15 : 1 to
9 : 1) provided O-methylmahanine A (7) as light yellow crystals,
yield: 72.2 mg (200 µmol, 75%), m.p. 181–182 °C (ref. 13:
126 °C). UV (MeOH): λ = 219, 241, 284 (sh), 294, 341 nm; Fluo-
rescence (MeOH): λex = 241 nm, λem = 357 nm; IR (ATR): ν =
3395, 3038, 3002, 2970, 2923, 2846, 1643, 1625, 1494, 1472,
1454, 1402, 1379, 1310, 1271, 1244, 1211, 1193, 1155, 1105,
1081, 1058, 1030, 1015, 980, 948, 915, 875, 829, 808, 777, 747,
721, 678, 641, 615, 580 cm−1; 1H NMR (500 MHz, CDCl3): δ =
1.44 (s, 3 H), 1.58 (s, 3 H), 1.66 (d, J = 0.8 Hz, 3 H), 1.76 (t, J =
8.4 Hz, 2 H), 2.10–2.23 (m, 2 H), 2.32 (d, J = 0.4 Hz, 3 H), 3.88
(s, 3 H), 5.11 (m, 1 H), 5.66 (d, J = 9.8 Hz, 1 H), 6.62 (d, J =
9.8 Hz, 1 H), 6.80 (dd, J = 8.5, 2.2 Hz, 1 H), 6.89 (d, J = 2.2 Hz,
1 H), 7.56 (s, 1 H), 7.77 (d, J = 8.5 Hz, 1 H), 7.78 (br s, 1 H);
13C NMR and DEPT (125 MHz, CDCl3): δ = 16.03 (CH3), 17.56
(CH3), 22.73 (CH2), 25.66 (CH3), 25.74 (CH3), 40.68 (CH2),
55.63 (CH3), 77.96 (C), 95.12 (CH), 104.26 (C), 107.61 (CH),
116.71 (C), 117.49 (CH), 117.88 (C), 118.24 (C), 119.89 (CH),
120.43 (CH), 124.19 (CH), 128.68 (CH), 131.65 (C), 134.70 (C),
140.63 (C), 148.90 (C), 157.89 (C); MS (EI): m/z (%) = 361 (91)
[M+], 346 (11), 278 (100), 240 (12), 239 (14); Elemental analysis
calcd for C24H27NO2: C 79.74, H 7.53, N 3.87; found: C 79.45,
H 7.69, N 3.88%.
Notes and references
1 (a) D. P. Chakraborty and S. Roy, in Progress in the Chem-
istry of Organic Natural Products, ed. W. Herz, H. Grisebach,
G. W. Kirby, W. Steglich and C. Tamm, Springer-Verlag,
Wien, 1991, vol. 57, p. 71; (b) H.-J. Knölker and K. R. Reddy,
Chem. Rev., 2002, 102, 4303; (c) D. P. Chakraborty and
S. Roy, in Progress in the Chemistry of Organic Natural Pro-
ducts, ed. W. Herz, H. Grisebach, G. W. Kirby, W. Steglich
and C. Tamm, Springer-Verlag, Wien, 2003, vol. 85, p. 125;
(d) A. W. Schmidt, K. R. Reddy and H.-J. Knölker, Chem.
Rev., 2012, 112, 3193.
2 (a) T. A. Choi, R. Czerwonka, R. Forke, A. Jäger, J. Knöll,
M. P. Krahl, T. Krause, K. R. Reddy, S. G. Franzblau and
H.-J. Knölker, Med. Chem. Res., 2008, 17, 374;
(b) H.-J. Knölker and K. R. Reddy, in The Alkaloids, ed.
G. A. Cordell, Academic Press, Amsterdam, 2008, vol. 65,
p. 1; (c) N. Kongkathip and B. Kongkathip, Heterocycles,
2009, 79, 121; (d) K. Thevissen, A. Marchand, P. Chaltin,
E. M. K. Meert and B. P. A. Cammue, Curr. Med. Chem.,
2009, 16, 2205; (e) T. Nagappan, P. Ramasamy,
M. E. A. Wahid, T. C. Segaran and C. S. Vairappan, Mole-
cules, 2011, 16, 9651.
3 (a) J. Bergmann and B. Pelcman, Pure Appl. Chem., 1990,
62, 1967; (b) U. Pindur, Chimia, 1990, 44, 406;
(c) T. Kawasaki and M. Sakamoto, J. Indian Chem. Soc.,
1994, 71, 443; (d) H.-J. Knölker, in Advances in Nitrogen
Heterocycles, ed. C. J. Moody, Jai Press Inc., Greenwich, CT,
1995, vol. 1, p. 173; (e) H.-J. Knölker, Curr. Org. Synth.,
2004, 1, 309; (f ) H.-J. Knölker, Top. Curr. Chem., 2005, 244,
115; (g) S. Agarwal, S. Cämmerer, S. Filali, W. Fröhner,
J. Knöll, M. P. Krahl, K. R. Reddy and H.-J. Knölker, Curr.
Org. Chem., 2005, 9, 1601; (h) H.-J. Knölker, Chem. Lett.,
2009, 38, 8; (i) M. Zhang, Adv. Synth. Catal., 2009, 351,
2243; ( j) R. Forke, K. K. Gruner, K. E. Knott, S. Auschill,
S. Agarwal, R. Martin, M. Böhl, S. Richter, G. Tsiavaliaris,
R. Fedorov, D. J. Manstein, H. O. Gutzeit and H.-J. Knölker,
Pure Appl. Chem., 2010, 82, 1975; (k) K. K. Gruner and
H.-J. Knölker, in Heterocycles in Natural Product Synthesis,
ed. K. C. Majumdar and S. K. Chattopadhyay, Wiley-VCH,
Weinheim, 2011, p. 341; (l) J. Roy, A. K. Jana and D. Mal,
Tetrahedron, 2012, 68, 6099; (m) I. Bauer and H.-J. Knölker,
Top. Curr. Chem., 2012, 309, 203.
4 (a) H.-J. Knölker, Chem. Soc. Rev., 1999, 28, 151;
(b) K. E. Knott, S. Auschill, A. Jäger and H.-J. Knölker,
Chem. Commun., 2009, 1467; (c) K. K. Gruner,
T. Hopfmann, K. Matsumoto, A. Jäger, T. Katsuki and
H.-J. Knölker, Org. Biomol. Chem., 2011, 9, 2057;
(d) C. Thomas, O. Kataeva and H.-J. Knölker, Synlett, 2011,
2663; (e) C. Börger, M. P. Krahl, M. Gruner, O. Kataeva and
H.-J. Knölker, Org. Biomol. Chem., 2012, 10, 5189;
(f ) M. P. Krahl, A. W. Schmidt and H.-J. Knölker, Hetero-
cycles, 2012, 86, 357; (g) M. P. Krahl, O. Kataeva,
A. W. Schmidt and H.-J. Knölker, Eur. J. Org. Chem., 2013,
59; (h) I. Bauer and H.-J. Knölker, in The Chemistry of Orga-
noiron Compounds – PATAI’s Chemistry of Functional Groups,
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2014 Org. Biomol. Chem., 2014, 12, 3866–3876 | 3875
O
pe
n 
A
cc
es
s 
A
rt
ic
le
. P
ub
lis
he
d 
on
 0
7 
A
pr
il 
20
14
. D
ow
nl
oa
de
d 
on
 1
7/
07
/2
01
4 
12
:5
3:
16
. 
 T
hi
s 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
C
om
m
on
s 
A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
L
ic
en
ce
.
View Article Online
ed. I. Marek and Z. Rappoport, Wiley, Chichester, 2014,
ch. 5, pp. 155.
5 (a) H.-J. Knölker and N. O’Sullivan, Tetrahedron, 1994, 50,
10893; (b) R. Forke, A. Jäger and H.-J. Knölker, Org. Biomol.
Chem., 2008, 6, 2481; (c) R. Forke, M. P. Krahl, F. Däbritz,
A. Jäger and H.-J. Knölker, Synlett, 2008, 1870;
(d) K. K. Gruner and H.-J. Knölker, Org. Biomol. Chem.,
2008, 6, 3902; (e) C. Börger, O. Kataeva and H.-J. Knölker,
Org. Biomol. Chem., 2012, 10, 7269; (f ) C. Börger and
H.-J. Knölker, Tetrahedron, 2012, 68, 6727; (g) T. Gensch,
M. Rönnefahrt, R. Czerwonka, A. Jäger, O. Kataeva, I. Bauer
and H.-J. Knölker, Chem. – Eur. J., 2012, 18, 770;
(h) L. Huet, R. Forke, A. Jäger and H.-J. Knölker, Synlett,
2012, 1230; (i) C. Thomas and H.-J. Knölker, Tetrahedron
Lett., 2013, 54, 591; ( j) A. Berndt, M. Gruner, A. W. Schmidt
and H.-J. Knölker, Synlett, 2013, 24, 2102; (k) R. Hesse,
K. K. Gruner, O. Kataeva, A. W. Schmidt and H.-J. Knölker,
Chem. – Eur. J., 2013, 19, 14098; (l) V. P. Kumar,
K. K. Gruner, O. Kataeva and H.-J. Knölker, Angew. Chem.,
Int. Ed., 2013, 52, 11073; (m) C. Thomas, O. Kataeva,
A. W. Schmidt and H.-J. Knölker, Org. Biomol. Chem., 2014,
12, 872.
6 H. Furukawa, C. Ito, M. Yogo and T.-S. Wu, Chem. Pharm.
Bull., 1986, 34, 2672.
7 C. Ito, M. Nakagawa, T.-S. Wu and H. Furukawa, Chem.
Pharm. Bull., 1991, 39, 1668.
8 C. Ito, M. Itoigawa, K. Nakao, T. Murata, M. Tsuboi,
N. Kaneda and H. Furukawa, Phytomedicine, 2006, 13, 359.
9 C. Ito, M. Nakagawa, T.-S. Wu and H. Furukawa, Chem.
Pharm. Bull., 1991, 39, 2525.
10 T.-S. Wu, Phytochemistry, 1991, 30, 1048.
11 Y. Tachibana, H. Kikuzaki, N. H. Lajis and N. Nakatani,
J. Agric. Food Chem., 2003, 51, 6461.
12 M. Chakraborty, S. Saha and S. Mukhapadhyay, Nat. Prod.
Commun., 2009, 4, 355.
13 F. Anwer, R. S. Kapil and S. P. Popli, Experientia, 1972, 28,
769.
14 M. Itoigawa, Y. Kashiwada, C. Ito, H. Furukawa,
Y. Tachibana, K. F. Bastow and K. H. Lee, J. Nat. Prod.,
2000, 63, 893.
15 (a) J. F. Hartwig, Angew. Chem., Int. Ed., 1998, 37, 2046;
(b) M. D. Charles, P. Schultz and S. L. Buchwald, Org. Lett.,
2005, 7, 3965–3968; (c) D. S. Surry and S. L. Buchwald,
Angew. Chem., Int. Ed., 2008, 47, 6338.
16 G. Eisenbrand and F. Hippe, WO 2003070703, 2003.
17 J. D. Godfrey Jr., R. H. Mueller, T. C. Sedergran,
N. Soundararajan and V. J. Colandrea, Tetrahedron Lett.,
1994, 35, 6405.
18 (a) I. Iwai and J. Ide, Chem. Pharm. Bull., 1962, 10, 926;
(b) I. Iwai and J. Ide, Chem. Pharm. Bull., 1963, 11, 1042;
(c) J. Hlubucek, E. Ritchie and W. C. Taylor, Tetrahedron
Lett., 1969, 10, 1369; (d) P. E. Brown and R. A. Lewis,
J. Chem. Soc., Perkin Trans. 1, 1992, 573.
19 J. Zsindely and H. Schmid, Helv. Chim. Acta, 1968, 51,
1510.
20 G. Sartori, G. Casiraghi, L. Bolzoni and G. Casnati, J. Org.
Chem., 1979, 44, 803.
21 (a) J. Tsuji, T. Sugiura and I. Minami, Synthesis, 1987, 603;
(b) S. Yamaguchi, M. Maekawa, Y. Murayama, M. Miyazawa
and Y. Hirai, Tetrahedron Lett., 2004, 45, 6971;
(c) S. Yamaguchi, M. Nedachi, M. Maekawa, Y. Murayama,
M. Miyazawa and Y. Hirai, J. Heterocycl. Chem., 2006,
43, 29.
22 H. E. Gottlieb, V. Kotlyar and A. Nudelman, J. Org. Chem.,
1997, 62, 7512.
23 L. J. Farrugia, J. Appl. Crystallogr., 1997, 30, 565.
Paper Organic & Biomolecular Chemistry
3876 | Org. Biomol. Chem., 2014, 12, 3866–3876 This journal is © The Royal Society of Chemistry 2014
O
pe
n 
A
cc
es
s 
A
rt
ic
le
. P
ub
lis
he
d 
on
 0
7 
A
pr
il 
20
14
. D
ow
nl
oa
de
d 
on
 1
7/
07
/2
01
4 
12
:5
3:
16
. 
 T
hi
s 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
C
om
m
on
s 
A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
L
ic
en
ce
.
View Article Online
